Theresa Heggie

Ms. Theresa M.
Heggie is an Independent Director at BioCryst Pharmaceuticals, Inc. and a Co-Managing Director at Alnylam Germany GmbH.
She is on the Board of Directors at ProQR Therapeutics NV, BioCryst Pharmaceuticals, Inc. and Alnylam UK Ltd. Ms. Heggie was previously employed as a Chief Executive Officer & Director by Freeline Therapeutics Holdings Ltd., a Senior Vice President, Head-EMEA & Canada Region by Alnylam Pharmaceuticals, Inc., an Independent Non-Executive Director by Swedish Orphan Biovitrum AB, a Chief Marketing & Strategy Officer by The British United Provident Association Ltd., a Senior Vice President-Global Commercial Operations by TRANSKARYOTIC THERAPIES INC, a Chief Executive Officer by Jerini AG, a Senior Vice President-Global Commercial Operations by Shire Plc, a Vice President-Global Marketing by Baxter International, Inc., a Principal by Janssen Pharmaceuticals, Inc., a Principal by Ohmeda Pharmaceuticals, and a Chief Executive Officer by Spur Therapeutics Ltd. She received her undergraduate degree from Cornell University.